GB9820294D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9820294D0
GB9820294D0 GBGB9820294.8A GB9820294A GB9820294D0 GB 9820294 D0 GB9820294 D0 GB 9820294D0 GB 9820294 A GB9820294 A GB 9820294A GB 9820294 D0 GB9820294 D0 GB 9820294D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9820294.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9820294.8A priority Critical patent/GB9820294D0/en
Publication of GB9820294D0 publication Critical patent/GB9820294D0/en
Priority to PCT/EP1999/006780 priority patent/WO2000017207A1/en
Priority to US10/801,510 priority patent/US20040176370A1/en
Ceased legal-status Critical Current

Links

GBGB9820294.8A 1998-09-17 1998-09-17 Pharmaceuticals Ceased GB9820294D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9820294.8A GB9820294D0 (en) 1998-09-17 1998-09-17 Pharmaceuticals
PCT/EP1999/006780 WO2000017207A1 (en) 1998-09-17 1999-09-14 3,4-dihydro -n-[[1-(3 -hydroxybutyl) -4-piperidinyl] methyl] -2h-[1,3] oxazino[3, 2-a]indole -10-carboxamide as 5-ht(4) receptor antagonist
US10/801,510 US20040176370A1 (en) 1998-09-17 2004-03-16 3,4-Dihdro-N-[[1-(3-hydroxybutyl)-4-piperidinyl]methyl]-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide as 5-HT(4) receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9820294.8A GB9820294D0 (en) 1998-09-17 1998-09-17 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9820294D0 true GB9820294D0 (en) 1998-11-11

Family

ID=10839042

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9820294.8A Ceased GB9820294D0 (en) 1998-09-17 1998-09-17 Pharmaceuticals

Country Status (2)

Country Link
GB (1) GB9820294D0 (en)
WO (1) WO2000017207A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0630376T3 (en) * 1992-03-12 1999-06-23 Smithkline Beecham Plc Condensed indole derivatives as 5-HT4 receptor antagonists
GB9316195D0 (en) * 1993-08-05 1993-09-22 Smithkline Beecham Plc Pharmaceuticals
CA2148700A1 (en) * 1992-11-05 1994-05-11 Laramie Mary Gaster Piperidine derivatives as 5-ht4 receptor antagonists
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
WO2000017207A1 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
EP1145714A4 (en) Drugs
GB9601544D0 (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9710928D0 (en) Pharmaceuticals
GB9804874D0 (en) Pharmaceuticals
GB9804892D0 (en) Pharmaceuticals
GB9823539D0 (en) Pharmaceuticals
GB9804557D0 (en) Pharmaceuticals
GB9801738D0 (en) Pharmaceuticals
GB9820294D0 (en) Pharmaceuticals
GB9725933D0 (en) Pharmaceuticals
GB9828707D0 (en) Pharmaceutical uses
GB9606745D0 (en) Pharmaceuticals
GB9721459D0 (en) Pharmaceuticals
GB9703886D0 (en) Pharmaceuticals
GB9707256D0 (en) Pharmaceuticals
GB9707257D0 (en) Pharmaceuticals
GB9700155D0 (en) Pharmaceuticals
GB9710931D0 (en) Pharmaceuticals
GB9714194D0 (en) Pharmaceuticals
GB9720689D0 (en) Pharmaceuticals
GB9706755D0 (en) Pharmaceuticals
GB9721470D0 (en) Pharmaceuticals
GB9705974D0 (en) Pharmaceuticals
GB9706754D0 (en) Pharmaceuticals

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)